Intestinal drug absorption enhancers: Synergistic effects of combinations

Drug Development and Industrial Pharmacy

Volumn 34, Issue 12, 2008, Pages 1343-1349

  Enslin, Gill M ^a   Hamman, Josias H ^a   Kotzé, Awie F ^b  

^a TSHWANE UNIVERSITY OF TECHNOLOGY   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Absorption enhancement; Caco 2 cells; Chitosan; Melittin; Monocaprin; Transepithelial electrical resistance

Indexed keywords

CHITOSAN DERIVATIVE; CHITOSAN LACTATE; DICARBOXYMETHYLCHITOSAN; N TRIMETHYLCHITOSAN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG ABSORPTION; DRUG PENETRATION; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE EPITHELIUM CELL; TRANSEPITHELIAL ELECTRICAL RESISTANCE;

CACO-2 CELLS; CHITOSAN; DRUG SYNERGISM; ELECTRIC IMPEDANCE; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION;

EID: 57349121138     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802098185     Document Type: Article

References (27)

1. Brown, J. R., Collett, J. H., Attwood, D., Ley, R. W., & Sims, E. E. (2002). Influence of monocaprin on the permeability of a diacidic drug BTA-243 across Caco-2 cell monolayers and everted gut sacs. Int. J. Pharm., 245, 133-142.
2. Cleland, J. L., Daugherty, A., & Mrsny, R. (2001). Emerging protein delivery methods. Curr. Opin. Biotechnol., 12, 212-219.
3. Dempsey, C. E. (1990). The actions of melittin on membranes. Biochim. Biophys. Acta, 1031, 143-161.
4. Dodane, V., Khan, M. A., & Merwin, J. R. (1999). Effect of chitosan on epithelial permeability and structure. Int. J. Pharm., 182, 21-32.
5. Gomez-Orellana, I. (2005). Strategies to improve oral drug bioavailability. Expert Opin. Drug. Deliv., 2, 419-433.
6. Hamman, J. H., Enslin, G. M., & Kotzé, A. F. (2005). Oral delivery of peptide drugs: Barriers and developments. BioDrugs, 19, 165-177.
7. Hamman, J. H., Schultz, C. M., & Kotzé, A. F. (2003). N-trimethyl chitosan chloride: Optimum degree of quaternization for drug absorption enhancement across epithelial cells. Drug Dev. Ind. Pharm., 29, 161-172.
8. Hejazi, R., & Amiji, M. (2003). Chitosan-based gastrointestinal delivery systems. J. Control. Release, 89, 151-165.
9. Illum, L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm. Res., 15, 1326-1331.
10. Jonker-Venter, C., Snyman, D., Janse van Rensburg, C., Jordaan, E., Schultz, C., Steenekamp, J. H., Hamman, J. H., & Kotzé, A. F. (2006). Low molecular weight quaternised chitosan (II): In vitro assessment of absorption enhancing properties. Pharmazie, 61, 301-305.
11. Junginger, H. E., & Verhoef, J. C. (1998). Macromolecules as safe penetration enhancers for hydrophilic drugs - a fiction. Pharm. Sci. Technol. Today, 1, 370-376.
12. Kotzé, A. F., De Leeuw, B. J., Lueßen, H. L., De Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1997). Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: In vitro evaluation in Caco-2 cell monolayers. Int. J. Pharm., 159, 243-253.
13. Kotzé, A. F., Thanou, M. M., Lueßen, H. L., De Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1999). Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). Eur. J. Pharm. Biopharm., 47, 269-274.
14. Lecluyse, E. L., & Sutton, S. C. (1997). In vitro models for selection of development candidates. Permeability studies to define mechanisms of absorption enhancement. Adv. Drug Deliv. Rev., 23, 163-183.
15. Liu, P., Davis, P., Liu, H., & Krishnan, T. R. (1999). Evaluation of cytotoxicity and absorption enhancing effects of melittin - a novel absorption enhancer. Eur. J. Pharm. Biopharm., 48, 85-87.
16. Lueßen, H. L., De Leeuw, B. J., Langemeÿer, W. E., De Boer, A. B. G., Verhoef, J. C., & Junginger, H. E. (1997). Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res., 13, 1668-1672.
17. Maher, S., Feighery, L., Brayden, D. J., & McClean, S. (2007a). Melittin as an epithelial permeability enhancer I: Investigation of its mechanism of action in caco-2 monolayers. Pharm. Res., 24, 1336-1345.
18. Maher, S., Feighery, L., Brayden, D. J., & McClean, S. (2007b). Melittin as an epithelial permeability enhancer II: In vivo investigations in human mucus secreting monolayers and rat colonic mucosae. Pharm. Res., 24, 1346-1356.
19. Paul, W., & Sharma, C. P. (2000). Chitosan, a drug carrier for the 21st century: A review. S.T.P. Pharma Sci., 10, 5-22.
20. Schipper, N. G. M., Vårum, K. M., & Artursson, P. (1996). Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm. Res., 13, 1686-1691.
21. Sharma, P., Varma, M. V. S., Chawla, H. P. S., & Panchagnula, R. (2005). Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. Farmaco, 60, 884-893.
22. Shen, W. (2003). Oral peptide and protein delivery: Unfulfilled promises. Drug Discov. Today, 8, 607-608.
23. Soltero, R., & Ekwuribe, N. (2001). The oral delivery of protein and peptide drugs. Innovations Pharm. Technol., 106-110.
24. Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001). Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev., 52, 117-126.
25. Van Hoogdalem, E. J., De Boer, A. G., & Breimer, D. D. (1989). Intestinal drug absorption enhancement: An overview. Pharm. Ther., 44, 407-443.
26. Ward, P. D., Tippin, T. K., & Thakker, D. K. (2000). Enhancing paracellular permeability by modulating epithelial tight junctions. Pharm. Sci. Technol. Today, 3, 346-358.
27. Zhou, X. H. (1994). Overcoming enzymatic and absorption barriers to nonparenterally administered protein and peptide drugs. J. Control. Release, 29, 239-252.